Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus

ABSTRACT Introduction: Systemic Lupus Erythematosus (SLE) mostly affects women during their childbearing years. Fertility is preserved in SLE patients, but pregnancy is often characterized by a high number of maternal and fetal complications. Adverse pregnancy outcomes (APO) have been widely studied over the last decades and several investigators have focused on the potential clinical and serological predictors of maternal and fetal complications. Areas covered: In this review, we analyzed maternal and fetal complications in SLE patients and predictors of APO. Active disease in the 6 months before conception, lupus nephritis, anti-phospholipid (aPL), anti-SSA/Ro and/or anti-SSB/La antibodies have been identified as the most consistent predictors of maternal and fetal complications to date. However, molecular mechanisms and underlying immunological pathways involved in APO still remain elusive. Expert opinion: Difficulties in assessing prevalence and predictors of APO in SLE patients are due to lack of uniformity in the definitions and methods used in the different studies. In addition, some maternal and fetal complications are difficult to diagnose and to differentiate from each other. Preconception counseling is paramount to prevent APO, and it should consider four main factors: disease activity/lupus nephritis, safety of drugs, aPL, anti-SSA/Ro, and/or anti-SSB/La antibodies.

[1]  R. Levy,et al.  The impact of different classes of lupus nephritis on maternal and fetal outcomes: a cohort study of 147 pregnancies , 2019, Lupus.

[2]  C. Bao,et al.  Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study , 2019, BMJ Open.

[3]  N. Jordan.  Management of pregnancy in systemic lupus erythematosus: What a GP should know , 2018, Lupus.

[4]  Dongying Chen,et al.  Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study , 2018, Journal of immunology research.

[5]  Simran Kaur Nahal,et al.  Safety issues and recommendations for successful pregnancy outcome in systemic lupus erythematosus. , 2018, Journal of autoimmunity.

[6]  K. Kongwattanakul,et al.  Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome , 2018, International journal of women's health.

[7]  P. Bundhun,et al.  Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis , 2018, BMC Pregnancy and Childbirth.

[8]  C. Ponticelli,et al.  Important considerations in pregnant patients with lupus nephritis , 2018, Expert review of clinical immunology.

[9]  Jiayue Wu,et al.  Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis , 2018, Therapeutics and clinical risk management.

[10]  J. Piette,et al.  Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies , 2018, Front. Immunol..

[11]  Dongying Chen,et al.  Role of foetal umbilical artery Doppler on prediction of adverse pregnancy outcomes in patients with systemic lupus erythematosus. , 2018, Clinical and experimental rheumatology.

[12]  M. Morizane,et al.  Factors associated with adverse pregnancy outcomes in women with systematic lupus erythematosus. , 2018, Journal of reproductive immunology.

[13]  M. Petri,et al.  Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus , 2018, Arthritis care & research.

[14]  Mimi Y. Kim,et al.  Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies , 2018, Annals of the rheumatic diseases.

[15]  Michael Doherty,et al.  The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies , 2017, Rheumatology.

[16]  J. V. van Laar,et al.  Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study , 2017, Journal of immunology research.

[17]  R. Fischer-Betz,et al.  Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. , 2017, Best practice & research. Clinical rheumatology.

[18]  P. Bundhun,et al.  Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: A meta-analysis of studies published between years 2001-2016. , 2017, Journal of autoimmunity.

[19]  C. Nelson-Piercy,et al.  Biomarkers for Adverse Pregnancy Outcomes in Rheumatic Diseases. , 2017, Rheumatic diseases clinics of North America.

[20]  M. Petri,et al.  Systemic Lupus Erythematosus and Pregnancy. , 2017, Rheumatic diseases clinics of North America.

[21]  A. Cerutti,et al.  Low titer, isolated anti Ro/SSA 60 kd antibodies is correlated with positive pregnancy outcomes in women at risk of congenital heart block , 2017, Clinical Rheumatology.

[22]  L. Espinoza,et al.  Prolactin has a pathogenic role in systemic lupus erythematosus , 2017, Immunologic research.

[23]  F. Dall’ara,et al.  A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. , 2016, Journal of autoimmunity.

[24]  P. Ravani,et al.  Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. , 2016, Journal of autoimmunity.

[25]  P. Ravani,et al.  Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. , 2016, Journal of autoimmunity.

[26]  L. Punzi,et al.  Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. , 2016, Journal of autoimmunity.

[27]  M. Clowse,et al.  Racial and Ethnic Disparities in the Pregnancies of Women With Systemic Lupus Erythematosus , 2016, Arthritis care & research.

[28]  S. Tavakolpour,et al.  New Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During Pregnancy , 2016, Scandinavian journal of immunology.

[29]  S. Aoki,et al.  Systemic lupus erythematosus: strategies to improve pregnancy outcomes , 2016, International journal of women's health.

[30]  C. Ponticelli,et al.  Pregnancy in women with systemic lupus erythematosus (SLE). , 2016, European journal of internal medicine.

[31]  Peng-Hui Wang,et al.  Increased risk of systemic lupus erythematosus in pregnancy-induced hypertension , 2016, Medicine.

[32]  L. Punzi,et al.  Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients , 2016, Lupus Science & Medicine.

[33]  R. Fischer-Betz,et al.  The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation , 2016, Annals of the rheumatic diseases.

[34]  E. Somers,et al.  Pregnancy and autoimmune connective tissue diseases. , 2016, Best practice & research. Clinical rheumatology.

[35]  G. Baron,et al.  Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. , 2015, Autoimmunity reviews.

[36]  Mimi Y. Kim,et al.  Predictors of Pregnancy Outcomes in Patients With Lupus , 2015, Annals of Internal Medicine.

[37]  R. Fischer-Betz,et al.  EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome , 2015, Annals of the rheumatic diseases.

[38]  K. Costenbader,et al.  Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy , 2015, Lupus.

[39]  J. Buyon,et al.  The clinical spectrum of autoimmune congenital heart block , 2015, Nature Reviews Rheumatology.

[40]  Dongying Chen,et al.  The Effects of Bromocriptine on Preventing Postpartum Flare in Systemic Lupus Erythematosus Patients from South China , 2015, Journal of immunology research.

[41]  A. Mantovani,et al.  PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis , 2015, Clinical Reviews in Allergy & Immunology.

[42]  J. Piette,et al.  [Systemic lupus erythematosus and antiphospholipid syndrome: How to manage pregnancy?]. , 2015, La Revue de medecine interne.

[43]  A. Sánchez,et al.  Primigravida is associated with flare in women with systemic lupus erythematosus , 2015, Lupus.

[44]  A. Shennan,et al.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.

[45]  E. Casiglia,et al.  Predictors of maternal and fetal complications in SLE patients: a prospective study , 2014, Immunologic research.

[46]  L. Jara,et al.  Risk factors of systemic lupus erythematosus flares during pregnancy , 2014, Immunologic Research.

[47]  K. Costenbader,et al.  Sexual disparities in the incidence and course of SLE and RA. , 2013, Clinical immunology.

[48]  James M. Roberts,et al.  Hypertension in Pregnancy: Executive Summary , 2013 .

[49]  M. Petri,et al.  Managing lupus patients during pregnancy. , 2013, Best practice & research. Clinical rheumatology.

[50]  Hanshi Xu,et al.  New-onset systemic lupus erythematosus during pregnancy , 2013, Clinical Rheumatology.

[51]  M. Weisman,et al.  Predictors of preterm birth in patients with mild systemic lupus erythematosus , 2013, Annals of the rheumatic diseases.

[52]  Mimi Y. Kim,et al.  Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus , 2012, Circulation.

[53]  V. Garovic,et al.  Maternal deaths in women with lupus nephritis: a review of published evidence , 2012, Lupus.

[54]  A. Larsson,et al.  Pentraxin 3 Values During Normal Pregnancy , 2011, Inflammation.

[55]  S. Bewley,et al.  Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis , 2011, The Journal of Rheumatology.

[56]  K. Joseph,et al.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. , 2011, Best practice & research. Clinical obstetrics & gynaecology.

[57]  L. Tam,et al.  Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus , 2011, Lupus.

[58]  J. Atkinson,et al.  Mutations in Complement Regulatory Proteins Predispose to Preeclampsia: A Genetic Analysis of the PROMISSE Cohort , 2011, PLoS medicine.

[59]  Kent R Bailey,et al.  A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[60]  E. Jaeggi,et al.  Non‐Cardiac Manifestations of Neonatal Lupus Erythematosus , 2010, Scandinavian journal of immunology.

[61]  A. Mantovani,et al.  IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus , 2010, Annals of the rheumatic diseases.

[62]  D. Gladman,et al.  The Effect of Lupus Nephritis on Pregnancy Outcome and Fetal and Maternal Complications , 2010, The Journal of Rheumatology.

[63]  V. Whiteman,et al.  Pre-eclampsia in the first pregnancy and subsequent risk of stillbirth in black and white gravidas. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[64]  R. Romero,et al.  Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation , 2010, Journal of perinatal medicine.

[65]  K. Nicolaides,et al.  Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy , 2009, Prenatal diagnosis.

[66]  M. Petri,et al.  Determinants of Risk for Venous and Arterial Thrombosis in Primary Antiphospholipid Syndrome and in Antiphospholipid Syndrome with Systemic Lupus Erythematosus , 2009, The Journal of Rheumatology.

[67]  J. Pope,et al.  Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) is Improving: Results from a Case Control Study and Literature Review , 2008, The open rheumatology journal.

[68]  D. Lê Thi Huong,et al.  [Pregnancy and systemic lupus erythematosus]. , 2008, La Revue de medecine interne.

[69]  So-Young Kim,et al.  Prognosis of Neonates in Pregnant Women with Systemic Lupus Erythematosus , 2008, Yonsei medical journal.

[70]  E. Myers,et al.  A national study of the complications of lupus in pregnancy. , 2008, American journal of obstetrics and gynecology.

[71]  D. Marcelli,et al.  Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  D. Isenberg,et al.  Systemic lupus erythematosus. , 2008, The New England journal of medicine.

[73]  L. Jara,et al.  Bromocriptine during Pregnancy in Systemic Lupus Erythematosus , 2007, Annals of the New York Academy of Sciences.

[74]  E. Chakravarty,et al.  Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[75]  L. Magder,et al.  Early Risk Factors for Pregnancy Loss in Lupus , 2006, Obstetrics and gynecology.

[76]  A. Tabor,et al.  Diagnostic criteria and reporting procedures for pre-eclampsia: a national survey among obstetrical departments in Denmark. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[77]  C. Laskin,et al.  Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. , 2005, The Journal of rheumatology.

[78]  L. Magder,et al.  The impact of increased lupus activity on obstetric outcomes. , 2005, Arthritis and rheumatism.

[79]  G. Hughes,et al.  Antiprothrombin antibodies detected in two different assay systems , 2005, Thrombosis and Haemostasis.

[80]  J. Rahman,et al.  Pregnancy outcome in lupus nephropathy , 2004, Archives of Gynecology and Obstetrics.

[81]  C. Laskin,et al.  Preterm deliveries in women with systemic lupus erythematosus. , 2003, The Journal of rheumatology.

[82]  Z. Zhan,et al.  [Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse]. , 2003, Zhonghua nei ke za zhi.

[83]  C. Ponticelli,et al.  The risk of pregnancy in patients with lupus nephritis. , 2003, Journal of nephrology.

[84]  A. Piccoli,et al.  Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. , 2002, Arthritis and rheumatism.

[85]  C. Ponticelli,et al.  Flares in lupus nephritis: Incidence, impact on renal survival and management , 1998, Lupus.

[86]  E. Silverman,et al.  U1RNP positive neonatal lupus erythematosus: association with anti‐La antibodies? , 1995, The British journal of dermatology.

[87]  I. Moga Sampere,et al.  [Pregnancy and systemic lupus erythematosus]. , 1993, Medicina clinica.

[88]  C. Lavalle,et al.  Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. , 1991, The Journal of rheumatology.

[89]  A. Galindo,et al.  The role of angiogenic biomarkers and uterine artery Doppler in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. , 2018, Pregnancy hypertension.

[90]  N. Weiss,et al.  A Population‐based Study of Perinatal Infection Risk in Women with and without Systemic Lupus Erythematosus and their Infants , 2018, Paediatric and perinatal epidemiology.

[91]  Mimi Y. Kim,et al.  Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. , 2016, American journal of obstetrics and gynecology.

[92]  G. Maruotti,et al.  HELLP syndrome and its relation with the antiphospholipid syndrome. , 2014, Blood transfusion = Trasfusione del sangue.

[93]  A. Leaños-Miranda,et al.  Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. , 2006, Rheumatology.

[94]  H. Julkunen.  Renal lupus in pregnancy. , 1998, Scandinavian journal of rheumatology. Supplement.

[95]  P. B. Eveleth,et al.  Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .

[96]  C. Nelson-Piercy,et al.  Open Access Rheumatology: Research and Reviews Dovepress Management of Systemic Lupus Erythematosus during Pregnancy: Challenges and Solutions , 2022 .